Report for quarter 4 and full-year 2024: Essity
Strong growth in fourth quarter ended a successful 2024
Quarter 4, 2024
- Net sales increased 3.2% to
SEK 37,805m (36,625) - Organic growth amounted to 3.9%, of which volume accounted for 1.7% and price/mix 2.2%. Excluding restructuring, organic growth increased 4.9%.
- EBITA decreased 1% to
SEK 4,585m (4,611) - EBITA excl. IAC increased 2% to
SEK 4,969m (4,853) - EBITA margin excl. IAC decreased 0.2 percentage points to 13.1% (13.3)
- ROCE decreased to 15.8% (16.2) and ROCE excl. IAC amounted to 17.1% (17.1)
- Profit for the period, total operations, amounted to
SEK 2,893m (2,891) - Earnings per share, continuing operations, increased to
SEK 4.13 (4.04). - Earnings per share, total operations, increased to
SEK 4.13 (4.02).
Full-year 2024
- Net sales decreased 1.1% to
SEK 145,546m (147,147) - Organic growth amounted to 0.2%, of which volume accounted for 0.5% and price/mix -0.3%. Excluding restructuring, organic growth increased 1.8%.
- EBITA increased 17% to
SEK 19,475m (16,607) - EBITA excl. IAC increased 8% to
SEK 20,344m (18,898) - EBITA margin excl. IAC increased 1.2 percentage points to 14.0% (12.8)
- ROCE increased to 16.9% (14.4) and ROCE excl. IAC increased to 17.6% (16.4)
- Profit for the period, total operations, amounted to
SEK 21,048m (9,796) - Earnings per share, continuing operations, increased to
SEK 17.09 (13.44). Earnings per share, total operations, increased toSEK 29.83 (13.60). - The Board of Directors proposes an increase in the dividend of 6.5% to
SEK 8.25 (7.75) per share. - President and CEO
Magnus Groth will leave Essity during 2025
CEO'S COMMENTS
Essity is in better shape than ever and our focus on accelerated profitable growth is yielding results. For full-year 2024, sales amounted to
Strong growth and crucial innovation
Sales increased in all of Essity's business areas in the fourth quarter. High organic growth was noted in our most profitable categories: Incontinence Products, in both healthcare and the retail trade, Medical Solutions, Feminine Care and, excluding restructuring, Professional Hygiene. Despite continued global economic challenges, our focus on accelerated profitable growth has yielded results. People are prioritizing hygiene and health and choosing the product offerings that can best improve their everyday lives, making relevant innovation crucial. Our launches of, for example, TENA Proskin Pants, incontinence products for better absorption and skin health, and improved Cutimed Sorbion wound dressings are examples of innovations that have contributed to our favorable performance. The latest major innovation is Tork Optiserve Coreless, a new toilet paper system that complements our big seller Tork PeakServe in Professional Hygiene.
Higher profit
Profit (EBITA excl. IAC) for the quarter was higher than in the year-earlier period. Higher volumes and sales prices, and a favorable product mix, had a positive impact. However, the EBITA margin excl. IAC was lower, mainly on account of higher costs in Consumer Goods and the Consumer Tissue category. The rapid and sharp strengthening of the USD increased costs, which has not yet been fully offset. Health & Medical and Professional Hygiene reported significantly higher margins. Our efficiency programs continued to generate high cost savings.
Successful 2024
2024 was a successful year. We achieved sales of
Leaving as CEO
After 14 years with the company and ten years as President and CEO, I have decided to leave Essity during 2025. Essity is today a global leading hygiene and health company with strong brands and market positions, fantastic employees and recognized sustainability work, reflected in profitable growth. I look forward to continuing to develop Essity with full speed together with my colleagues until my successor is in place.
Invitation to presentation
President and CEO
Link to the live presentation, which can also be viewed afterwards:
https://essity.videosync.fi/2025-01-23
Contact information for conference call with the possibility to ask questions:
SWE: +46 (0) 8 505 204 24
Please call in well in advance of the start of the presentation. Indicate: "Essity".
For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, tel: +46 (0) 70 564 96 89
Per Lorentz, Vice President Corporate Communications, tel: +46 (0) 73 313 30 55
NB: This information is such information that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of
This report has not been reviewed by the company's auditors.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/essity/r/report-for-quarter-4-and-full-year-2024,c4094876
The following files are available for download:
Essity Report ENG |
View original content:https://www.prnewswire.com/news-releases/report-for-quarter-4-and-full-year-2024-essity-302358289.html
SOURCE Essity
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Scale Marketing Names Industry Veteran Christine Formenti Vice President of Traditional Media
- Shark Tank Winner and Johns Hopkins Finance Professor Releases "The Social Security Playbook" -- A Decision-First Guide to the $182,000 Mistake Millions of Retirees Make
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Dividend, Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share